EuBiologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	518,900	443,892	418,137	324,359	1,271,414	655,399
Market Cap Growth	23.94%	6.16%	28.91%	-74.49%	93.99%	-
Enterprise Value	-	440,624	418,132	320,550	-	-
Last Close Price	14130.00	12150.00	11470.00	8900.00	35050.00	21300.00
PE Ratio	20.87	17.85	-	-	-	-
PS Ratio	5.40	4.62	6.03	5.85	32.28	23.01
PB Ratio	-	-	3.99	2.72	10.84	6.77
P/TBV Ratio	-	-	3.88	2.66	10.75	6.87
P/FCF Ratio	-	-	21.43	-	-	-
P/OCF Ratio	-	-	15.81	50.37	-	395.02
EV/Sales Ratio	-	4.59	6.03	5.78	-	-
EV/EBITDA Ratio	-	-	24.79	77.93	-	-
EV/EBIT Ratio	-	12.84	54.31	-	-	-
EV/FCF Ratio	-	-	21.43	-	-	-
Debt / Equity Ratio	-	-	0.14	0.13	0.13	0.23
Debt / EBITDA Ratio	-	-	0.88	3.81	-	-
Debt / FCF Ratio	-	-	0.76	-	-	-
Net Debt / Equity Ratio	-	-	0.03	0.04	-0.14	-0.33
Net Debt / EBITDA Ratio	-	-	0.20	1.08	24.27	2448.65
Net Debt / FCF Ratio	-	-	0.17	-1.69	1.14	5.07
Asset Turnover	-	-	0.44	0.36	0.26	-
Inventory Turnover	-	-	2.26	1.95	2.01	-
Quick Ratio	-	-	0.78	0.59	1.99	1.65
Current Ratio	-	-	1.63	1.67	3.11	2.03
Return on Equity (ROE)	-	-	-13.70%	-2.90%	-26.17%	-
Return on Assets (ROA)	-	-	3.07%	-1.51%	-2.95%	-
Return on Capital Employed (ROCE)	-	-	6.10%	-2.70%	-5.40%	-4.90%
Earnings Yield	4.79%	5.60%	-3.32%	-0.34%	-2.17%	-9.18%
FCF Yield	-	-	4.67%	-0.81%	-1.12%	-0.97%
Buyback Yield / Dilution	-	-	-0.13%	-2.68%	-26.53%	-

Source: S&P Capital IQ. Standard template. Financial Sources.